NeuroPace (NPCE) Enterprise Value (2020 - 2026)

NeuroPace's Enterprise Value history runs 7 years deep, the most recent figure standing at -$54.0 million for Q1 2026.

• On a quarterly basis, Enterprise Value rose 18.53% year-over-year to -$54.0 million in Q1 2026; TTM through Mar 2026 was -$54.0 million, a 18.53% increase from a year earlier, with the FY2025 full-year figure at -$61.1 million, down 15.74% from the prior year.
• Enterprise Value rose to -$54.0 million in Q1 2026 per NPCE's latest filing, from -$61.1 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$52.8 million in Q4 2024 and bottomed at -$103.2 million in Q1 2022.
• The 5-year median for Enterprise Value is -$62.1 million (2025), against an average of -$67.3 million.
• Across the five-year window, Enterprise Value tumbled 237.95% in 2022 and soared 34.47% in 2023, its largest moves.
• Year by year, Enterprise Value stood at -$77.4 million in 2022, then grew by 14.15% to -$66.5 million in 2023, then grew by 20.61% to -$52.8 million in 2024, then fell by 15.74% to -$61.1 million in 2025, then climbed by 11.59% to -$54.0 million in 2026.
• Per Business Quant, the three latest NPCE Enterprise Value figures stand at -$54.0 million (Q1 2026), -$61.1 million (Q4 2025), and -$60.0 million (Q3 2025).